April 30th 2024
Pemivibart will act as an additional preventive option for COVID-19 among moderately-to-severely immunocompromised adult and adolescent patients, who are disproportionally impacted by the condition.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Part 2: NACDS Discusses NY Law Allowing Pharmacy-Provided COVID-19 Vaccinations
July 29th 2020In part 2 of our interview, Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.
Smell Disturbances in the Era of COVID-19
Some patients affected by COVID-19 may be concerned about hyposmia (reduced ability to smell) or anosmia (loss of smell) that they experience after contracting the virus.
Part 2: Innovations in AI Amid COVID-19
July 7th 2020Drug Topics interviews Steve Mok, PharmD, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence can mitigate challenges posed by the COVID-19 pandemic.